Last Updated: June 9, 2026

Suppliers and packagers for ULTRAVIST 300 IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


ULTRAVIST 300 IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bayer Hlthcare ULTRAVIST 300 IN PLASTIC CONTAINER iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-05 10 VIAL, GLASS in 1 CARTON (50419-344-05) / 50 mL in 1 VIAL, GLASS 2009-12-30
Bayer Hlthcare ULTRAVIST 300 IN PLASTIC CONTAINER iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-10 10 VIAL, GLASS in 1 CARTON (50419-344-10) / 100 mL in 1 VIAL, GLASS 2009-12-30
Bayer Hlthcare ULTRAVIST 300 IN PLASTIC CONTAINER iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-12 10 VIAL, GLASS in 1 CARTON (50419-344-12) / 125 mL in 1 VIAL, GLASS 2009-12-30
Bayer Hlthcare ULTRAVIST 300 IN PLASTIC CONTAINER iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-344-15 10 VIAL, GLASS in 1 CARTON (50419-344-15) / 150 mL in 1 VIAL, GLASS 2009-12-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

ULTRAVIST 300 IN PLASTIC CONTAINER: Suppliers and Supply-Side Entities

Last updated: April 25, 2026

Who supplies ULTRAVIST 300 in plastic containers?

Public, supplier-level attribution depends on the specific market (by country) and the exact presentation and pack configuration for “ULTRAVIST 300 in plastic container.” With the information available in this request, there is no verifiable dataset tying ULTRAVIST 300 (iopromide) presentations to named manufacturing sites, packers, or distributor-suppliers for plastic containers.

What supplier facts can be confirmed from the provided prompt?

None. The prompt names the product and a container type but provides no dossier identifiers, regulatory filings, product labels, marketing authorization holders by jurisdiction, nor country-specific packaging artwork that would allow traceable supplier identification.

What data is typically required to identify suppliers for this presentation?

To name suppliers with evidence, the analysis must be anchored to at least one of the following for the exact presentation “ULTRAVIST 300 in plastic container”:

  • A country-specific product label or leaflet stating the marketing authorization holder and the manufacturer/packager (often “manufactured by” and “packed by” sections).
  • The SmPC/PI and regulatory EPAR/EMA national registration documents that list manufacturing and batch release sites.
  • The National Drug Register entry that enumerates the manufacturer and packaging site for that exact form and container.
  • The tender/contract supply listing used by hospitals or national distributors, identifying the named supplier entity per country.

Supplier map (evidence-based)

No evidence is available in the request to populate a supplier map.

Supplier type What to list Status for this request
Marketing authorization holder Company name per jurisdiction Not provided
Manufacturing site Site name and address for drug substance/drug product Not provided
Packer/secondary packaging Company and site for the plastic container presentation Not provided
Distributor/supplier Named distributor entity for that presentation Not provided
Country-specific registration Country register ID and presentation code Not provided

What can be concluded for R&D or procurement decisions

No supplier list can be generated accurately from the single product phrase “ULTRAVIST 300 IN PLASTIC CONTAINER” without the jurisdictional and label-level identifiers needed to tie the presentation to specific manufacturing and packaging entities.


Key Takeaways

  • The prompt does not include the jurisdictional label, regulatory dossier identifiers, or manufacturer/packager sections needed to name suppliers for “ULTRAVIST 300 in plastic container.”
  • A supplier list cannot be produced without evidence tied to the exact presentation in a specific market.

FAQs

  1. Can ULTRAVIST 300 suppliers be identified from the product name alone?
    Not reliably. Supplier identification requires label or regulatory documentation for the specific presentation and country.

  2. What is usually the fastest way to identify the supplier for a packaged pharmaceutical presentation?
    The marketing authorization label or SmPC/PI section that lists the manufacturer and packer for that exact formulation.

  3. Do packaging differences (plastic container vs other containers) change the supplier?
    They can. The drug product may be the same, while the packaging/secondary packaging site and packer can differ by presentation.

  4. Are suppliers the same across countries for ULTRAVIST 300?
    Often they vary by market depending on registrations, batch release sites, and distribution contracts.

  5. What specific documents are evidence-grade for supplier identification?
    Product leaflets/labels, SmPC/PI, national drug register entries, and batch release or tender documentation that names manufacturer/packer entities.

References

[1] EMA. EPAR/European public assessment reports for iopromide-containing products (requires the specific product/market identification).
[2] National drug registers (by country) for presentation-specific manufacturer and packager listings (requires jurisdiction and presentation code).
[3] EU/EEA product labeling and SmPC/PI templates for identifying “manufacturer” and “packed by” entities (requires the exact labeled presentation).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.